Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dopamine hydrochloride (substance) |
Is a |
False |
Dopamine (substance) |
Inferred relationship |
Some |
|
Dopamine adverse reaction |
Causative agent |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
Dopamine measurement, urine |
Component |
False |
Dopamine (substance) |
Inferred relationship |
Some |
2 |
Dopamine measurement, blood |
Component |
False |
Dopamine (substance) |
Inferred relationship |
Some |
2 |
Dopamine measurement |
Component |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
Product containing dopamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
24 hour urine dopamine output measurement |
Component |
False |
Dopamine (substance) |
Inferred relationship |
Some |
2 |
Dopamine/creatinine ratio measurement |
Component |
False |
Dopamine (substance) |
Inferred relationship |
Some |
3 |
24 hour urine free dopamine output measurement |
Component |
False |
Dopamine (substance) |
Inferred relationship |
Some |
2 |
Urine free dopamine measurement |
Component |
False |
Dopamine (substance) |
Inferred relationship |
Some |
2 |
Dopamine in Glucose 800micrograms/mL intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine (substance) |
Inferred relationship |
Some |
|
Serum dopamine measurement (procedure) |
Component |
False |
Dopamine (substance) |
Inferred relationship |
Some |
2 |
dopaminhydrochlorid 400 mg/glucose infusionsvæske, opløsning, hætteglas a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine (substance) |
Inferred relationship |
Some |
|
dopaminhydrochlorid 800 mg glucose infusionsvæske, opløsning, hætteglas a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine (substance) |
Inferred relationship |
Some |
|
dopaminhydrochlorid 40 mg/ml injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine (substance) |
Inferred relationship |
Some |
|
dopaminhydrochlorid 80 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine (substance) |
Inferred relationship |
Some |
|
dopaminhydrochlorid 40 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine (substance) |
Inferred relationship |
Some |
|
dopaminhydrochlorid 80 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine (substance) |
Inferred relationship |
Some |
|
dopaminhydrochlorid 40 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine (substance) |
Inferred relationship |
Some |
|
dopaminhydrochlorid i glucose 400 mg/250 ml infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dopamine (substance) |
Inferred relationship |
Some |
|
Allergy to dopamine |
Causative agent |
False |
Dopamine (substance) |
Inferred relationship |
Some |
|
Allergy to dopamine |
Causative agent |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
Product containing dopamine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
Dopamine hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dopamine (substance) |
Inferred relationship |
Some |
|
Dopamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
Product containing only dopamine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
Dopamine/creatinine ratio measurement |
Component |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
Urine free dopamine measurement |
Component |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
Dopamine measurement, urine |
Component |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
Dopamine measurement, blood |
Component |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
24 hour urine free dopamine output measurement |
Component |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
24 hour urine dopamine output measurement |
Component |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |
Serum dopamine measurement (procedure) |
Component |
True |
Dopamine (substance) |
Inferred relationship |
Some |
1 |